Profil
Neil Smith has worked as a Director at Modulate Therapeutics, Inc. since 2015 and as Head-Operations and VP-Research & Development at Censa Pharmaceuticals, Inc. since 2016.
Postes actifs de Neil Smith
| Sociétés | Poste | Début |
|---|---|---|
Modulate Therapeutics, Inc.
 Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Directeur/Membre du Conseil | 01/01/2015 |
Censa Pharmaceuticals, Inc.
 Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Directeur des opérations | 01/10/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Modulate Therapeutics, Inc.
Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Health Technology |
Censa Pharmaceuticals, Inc.
Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Health Technology |
